HomeComparePRSR vs ABBV

PRSR vs ABBV: Dividend Comparison 2026

PRSR yields 42.19% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRSR wins by $221.2K in total portfolio value
10 years
PRSR
PRSR
● Live price
42.19%
Share price
$4.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$261.1K
Annual income
$46,116.97
Full PRSR calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — PRSR vs ABBV

📍 PRSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRSRABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRSR + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
PRSR pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRSR
Annual income on $10K today (after 15% tax)
$3,586.50/yr
After 10yr DRIP, annual income (after tax)
$39,199.42/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, PRSR beats the other by $38,218.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRSR + ABBV for your $10,000?

PRSR: 50%ABBV: 50%
100% ABBV50/50100% PRSR
Portfolio after 10yr
$150.5K
Annual income
$23,635.70/yr
Blended yield
15.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

PRSR
No analyst data
Altman Z
2.2
Piotroski
1/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRSR buys
0
ABBV buys
0
No recent congressional trades found for PRSR or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRSRABBV
Forward yield42.19%3.67%
Annual dividend / share$2.00$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR0%8.9%
Portfolio after 10y$261.1K$39.9K
Annual income after 10y$46,116.97$1,154.43
Total dividends collected$199.5K$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRSR vs ABBV ($10,000, DRIP)

YearPRSR PortfolioPRSR Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$14,919$4,219.41$11,520$399.75+$3.4KPRSR
2$21,847$5,883.28$13,261$450.98+$8.6KPRSR
3$31,428$8,051.50$15,255$508.41+$16.2KPRSR
4$44,452$10,824.68$17,536$572.74+$26.9KPRSR
5$61,873$14,309.10$20,145$644.78+$41.7KPRSR
6$84,818$18,613.83$23,126$725.38+$61.7KPRSR
7$114,603$23,847.23$26,532$815.52+$88.1KPRSR
8$152,738$30,113.42$30,420$916.26+$122.3KPRSR
9$200,938$37,508.48$34,855$1,028.80+$166.1KPRSR
10$261,121$46,116.97$39,914$1,154.43+$221.2KPRSR

PRSR vs ABBV: Complete Analysis 2026

PRSRStock

Prospector Capital Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in La Jolla, California.

Full PRSR Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this PRSR vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRSR vs SCHDPRSR vs JEPIPRSR vs OPRSR vs KOPRSR vs MAINPRSR vs JNJPRSR vs MRKPRSR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.